Global Nocturia Market Growth Accelerates: Strategic Forecast Predicts $4.2 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Nocturia Industry Market Size Be by 2025?
The market encompassing nocturia has experienced substantial expansion lately, projected to advance from a valuation of $2.87 billion in the year 2024 to reach $3.1 billion by 2025, reflecting an annual growth rate compounded at 8.0%. This upward trajectory witnessed during the recent past stems from several factors, including the escalating frequency of cardiovascular illnesses, a surge in new cases of insomnia, the expanding demographic of older individuals, heightened public cognizance regarding nocturia and associated ailments, and the growing presence of multiple concurrent health conditions in patients.

What's the Long-Term Growth Forecast for the Nocturia Market Size Through 2029?
Anticipated within the coming years is substantial expansion for the nocturia market, projecting its valuation to reach $4.2 billion by 2029, underpinned by a compound annual growth rate (CAGR) of 7.8%. This upward trajectory throughout the projection timeframe is fueled by several factors: a growing occurrence of conditions involving bladder obstruction and urinary tract irritation, the escalating frequency of nighttime urine overproduction (nocturia) linked to diverse risk elements, elevated consumption of beverages leading to nocturia, heightened recognition regarding nocturia's relationship with both sleep disturbances and renal wellbeing, alongside the demographic shift towards an older populace. Key developments influencing this period encompass progress in diagnostic methodologies, innovation in pharmaceutical creation, boosted funding and investigation into curative approaches for nocturia, enhancements across both invasive and non-invasive treatment modalities, and the broader implementation of individualized medical protocols.

View the full report here:
https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

What Are the Key Growth Drivers Fueling the Nocturia Market Expansion?
An anticipated expansion in the nocturia market is forecast, largely fueled by the increasing incidence of ailments affecting the heart and circulatory system. These cardiovascular diseases, encompassing issues like stroke, coronary artery disease, and elevated blood pressure, are becoming more common due to several contributing factors such as lifestyle choices like inactivity and poor nutrition, increased smoking and alcohol use, rising obesity rates, hypertension, high cholesterol, diabetes, genetic influences, and the general aging of the populace. Symptomatically, individuals suffering from these cardiac and vascular problems frequently report nocturia, which consequently increases the need for diagnostic tools and therapeutic interventions. Given the global escalation of these cardiovascular issues, often linked to demographic shifts toward older ages and contemporary unhealthy habits, the requirement for successful nocturia control measures is set to escalate. As an illustration of the impact, data from the US Centers for Disease Control and Prevention in May 2024 revealed that in 2022, heart disease caused 702,880 deaths across the United States, accounting for one-fifth of all mortalities; additionally, around 805,000 people suffer a heart attack yearly in the US, broken down into 605,000 initial incidents and 200,000 recurrences among those previously affected. Consequently, the upswing in cardiovascular disease presence serves as a primary catalyst for the advancement of the nocturia market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

What Are the Key Trends Driving Nocturia Market Growth?
Key players within the nocturia sector are concentrating their efforts on forging novel solutions, for example, tablets that dissolve in the mouth, aiming to boost both patient ease of use and adherence to treatment. These orally disintegrating tablets, or ODTs, represent a solid medication form engineered to rapidly disperse inside the oral cavity irrespective of water intake, thus offering a superior option for individuals struggling with dysphagia. Illustratively, in July of 2024, Adalvo Limited, a pharmaceutical entity situated in Malta, introduced Desmopressin ODT across European territories for addressing ailments characterized by excessive bodily fluid loss, such as central cranial diabetes insipidus. This synthesized analogue of the vasopressin tablet serves to manage diabetes insipidus, abnormal levels of thirst and urinary output, and nocturnal enuresis by replicating the effects of the natural hormone, thereby restricting the volume of water expelled through urine. Furthermore, it finds application in controlling hemorrhaging associated with mild to moderate hemophilia A and von Willebrand disease through encouraging the secretion of blood coagulation agents.

How Is the Nocturia Market Segmented?
The nocturiamarket covered in this report is segmented -

1) By Drug: Anticholinergic Drugs; Desmopressin; Antibiotics; Antispasmodic; Other Drugs
2) By Indication: Mixed Nocturia; Low Nocturnal Bladder Capacity; Nocturnal Polyuria; Global Polyuria
3) By Causes: Urological Infection; Tumor Of The bladder; Diuretic Medications; Regular Alcohol Or coffee; Liver infection; Diabetes; Pregnancy; Other Causes
4) By End User: Hospitals; Home Care; Clinics

Subsegments:
1) By Anticholinergic Drugs: Oxybutynin; Tolterodine; Solifenacin; Darifenacin; Fesoterodine
2) By Desmopressin: Intranasal Desmopressin; Oral Desmopressin
3) By Antibiotics: Nitrofurantoin; Trimethoprim; Fosfomycin; Other Antibiotics
4) By Antispasmodic: Hyoscine Butylbromide; Flavoxate; Other Antispasmodics
5) By Other Drugs: Alpha-blockers; Beta-3 Agonists; Diuretics; Other Pharmacological Treatments

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21232&type=smp

Which Companies Are Leading the Charge in Nocturia Market Innovation?
Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

Which Regions Are Leading the Global Nocturia Market in Revenue?
North America was the largest region in the nocturia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21232

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.